Back
Innoviva 10K Form
Buy
52
INVA
Innoviva
Last Price:
$17.39
Seasonality Move:
7.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INVA News And Ratings
See the #1 stock for the next 7 days that we like better than INVA
INVA Financial Statistics
Sales & Book Value
| Annual Sales: | $358.7M |
|---|---|
| Cash Flow: | $55.2M |
| Price / Cash Flow: | 7.46 |
| Annual Sales: | $11.03 |
| Price / Book: | 1.57 |
Profitability
| EPS (TTM): | 0.19000 |
|---|---|
| Net Income (TTM): | $23.4M |
| Gross Margin: | $322.1M |
| Return on Equity: | 3.44% |
| Return on Assets: | 1.87% |
Innoviva Earnings Forecast
Key Innoviva Financial Ratios
-
The Gross Profit Margin over the past 25 years for INVA is 89.80%.
-
The Selling, General & Administrative Expenses for INVA have been equal to 32.25% of Gross Profit Margin.
-
The Research & Development expenses have been 3.81% of Revenue.
-
The Interest Expense is 94.94% of Operating Income.
-
The Net Earning history of INVA is 6.52% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 16 years.
Innoviva Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | INVA |
| CUSIP: | 45781M |
| Website: | inva.com |
Debt
| Debt-to-Equity Ratio: | 0.65 |
|---|---|
| Current Ratio: | 2.35 |
| Quick Ratio: | 2.11 |
Price-to-Earnings
| Trailing P/E Ratio: | 48.14 |
|---|---|
| Forward P/E Ratio: | 11.95 |